EBC

EBC launches statement on the impact of COVID-19 on brain health

The European Brain Council (EBC) is very pleased to announce the launch of updated disease fact sheets, providing a quick overview of key facts, history, known causes, diagnosis, symptoms and treatment of brain disorders – neurological and mental alike.

The call for applications for the Brain Innovation Days Pitch Competition, “My start-up in 180 seconds”, is currently open!

The European Brain Council and beLean.net are happy to announce the digital launch of the Brain Innovation Days, to be held on 13 October 2020 at 12:30-14:30.

The EBC releases its 2019 Annual Report

The European Brain Research Area project – EBRA – was created as a catalyzing platform for brain research stakeholders (researchers, clinicians, patients, governments, funders and public institutions) to streamline and better coordinate brain research across Europe.

The European Brain Council (EBC) has launched a new video series, “Science and Society”, to raise awareness of brain disorders and for those living with these conditions.

RETHINKING MS in Europe, offering tangible policy changes to improve the lives of people living with MS across Europe, went live during Brain Awareness Week On the occasion of the Brain Awareness Week (16-22 March 2020), the European Brain Council… Continue Reading

Meeting of WHO with EFNA, EAN and EBC to discuss brain health Report Objectives: Platform for all participants to present their ongoing work and discuss potential collaboration in the area of brain health Participants: European Academy of Neurology (EAN): Raad… Continue Reading

The first public event of the EBRA-project was held on 5 December 2019 in Brussels, Belgium.

The AD Detect and Prevent project, which is funded through Horizon 2020 and led by the Danish digital therapeutics company Brain+, aims to develop a robust digital tool for improving the early detection of Alzheimer’s disease (AD). This integrated tool aims to first detect subtle cognitive signs associated with Alzheimer’s disease (before the possible emergence of clear symptoms) and to subsequently provide personalized intervention programmes that address risk factors connected to Alzheimer’s dementia.

In 2018, EBC launched a wide range of events, projects and advocacy initiatives aimed at promoting brain research and addressing the disease burden of mental and neurological conditions.

Science|Business is canvassing views on the big research priorities for the next term of the EU, from 2019 to 2024. Here, six policy experts discuss the most pressing items on the EU’s to-do list for health.

In the continuity of the Value of Treatment research activities, new case studies have been developed on new therapeutic areas. On March 26th, May 23rd and September 24th 2018, EBC in collaboration with the European Academy of Neurology (EAN) and the European Federation of Neurological Associations (EFNA) launched a second round “VoT2” of case studies on Rare Neurological Disorders (RNDs) focusing upon Ataxia, Dystonia and Phenylketonuria

Publication on the roles of the medical profession and the industry on CME The BioMedical Alliance is a unique organisation representing 30 leading European medical societies (including EAN) that together represent more than 400,000 researchers and health professionals.